Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA)

ClinicalTrials.gov ID: NCT03841357

Public ClinicalTrials.gov record NCT03841357. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 3:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open Label, Multi-Center, Phase 3 Efficacy Study of Sub-Q Abatacept in Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA)

Study identification

NCT ID
NCT03841357
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Duke University
Other
Enrollment
121 participants

Conditions and interventions

Interventions

  • Abatacept Injection Drug
  • Usual Care Other

Drug · Other

Eligibility (public fields only)

Age range
2 Years to 16 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 28, 2019
Primary completion
Jan 21, 2025
Completion
Jan 21, 2025
Last update posted
Jan 22, 2026

2019 – 2025

United States locations

U.S. sites
19
U.S. states
16
U.S. cities
19
Facility City State ZIP Site status
University of California at San Francisco Medical Center San Francisco California 94143
The Children's Hospital Colorado Aurora Colorado 80045
Shands at the University of Florida Gainesville Florida 32610
Riley Hospital for Children at Indiana University Health Indianapolis Indiana 46202
University of Iowa Hospitals of Clinics Iowa City Iowa 52242
University of Louisville School of Medicine/ Norton Charities Pediatric Clinical Research Unit Louisville Kentucky 40202
Boston Children's Hospital Boston Massachusetts 02115
University of Minnesota; Children's Hospital and Clinics of Minnesota Minneapolis Minnesota 55454
Mayo Clinic Rochester Minnesota 55905
Hackensack University Medical Center Hackensack New Jersey 07601
Children's Hospital at Montefiore/ Albert Einstein University Hospital The Bronx New York 10461
University of North Carolina Chapel Hill North Carolina 27514
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
MetroHealth System Cleveland Ohio 44109
Nationwide Children's Hospital Columbus Ohio 43205
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Monroe Carell Jr Children's Hospital at Vanderbilt Nashville Tennessee 37232
University of Utah Salt Lake City Utah 84158
Seattle Children's Hospital Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03841357, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 22, 2026 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03841357 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →